Galvanize Therapeutics Stock

galvanizetx.com/HealthcareFounded: 2022

Galvanize Therapeutics, headquartered in San Carlos, California, is a biomedical platform company that serves leading life-changing solutions utilizing engineering, biology, and healthcare delivery to patients and healthcare organizations. Galvanize Therapeutics created Pulsed Electric Field technologies that enable cell targeting for disease processes, that treat in ways unparalleled to other devices or drugs.

Register for Details

For more details on financing and valuation for Galvanize Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Galvanize Therapeutics.

Register Today

Galvanize Therapeutics investors also invested in these private companies

Apple Tree Partners
Gilmartin Capital LLC
Intuitive Surgical

Team

Management Team

Jonathan Waldstreicher, MD
Founder and Chief Executive Officer
Kevin Taylor
Chief Operating Officer
Deb Sheffield
Senior Vice President, Regulatory and Quality Affiars
James Stambaugh
Senior Vice President, Clinical Affairs
William S. Krimsky, MD, FCCP, DAABIP
Chief Medical Officer
Bill Green
Senior Vice President, Sales and Marketing Oncology
Michael Iversen
Vice President, Business Development and Commercial Strategy
Steve Ricottone
Vice President, Global Market Development

Board Members

Doug Godshall, CHAIR
President and CEO, Shockwave Medical
Anna Batarina, CFA
Partner, ATP
Seth Harrison, MD
Founder and Managing Partner, ATP
Mohit Trikha, PhD
Venture Partner, ATP

Other companies like Galvanize Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

Gala Therapeutics and Galaxy Medical will be folded into Galvanize Therapeutics to continue to develop their electric pulse therapies for bronchitis, cardiac arrhythmias and solid tumors.